<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rada P</submitter><funding>NIDDK NIH HHS</funding><pagination>1187-1208</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9545809</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>28(13)</volume><pubmed_abstract>&lt;h4>Aims&lt;/h4>Sirtuin 1 (SIRT1) is a key player in liver physiology and a therapeutic target against hepatic inflammation. We evaluated the role of SIRT1 in the proinflammatory context and oxidative stress during acetaminophen (APAP)-mediated hepatotoxicity.&lt;h4>Results&lt;/h4>SIRT1 protein levels decreased in human and mouse livers following APAP overdose. SIRT1-Tg mice maintained higher levels of SIRT1 on APAP injection than wild-type mice and were protected against hepatotoxicity by modulation of antioxidant systems and restrained inflammatory responses, with decreased oxidative stress, proinflammatory cytokine messenger RNA levels, nuclear factor kappa B (NFκB) signaling, and cell death. Mouse hepatocytes stimulated with conditioned medium of APAP-treated macrophages (APAP-CM) showed decreased SIRT1 levels; an effect mimicked by interleukin (IL)1β, an activator of NFκB. This negative modulation was abolished by neutralizing IL1β in APAP-CM or silencing p65-NFκB in hepatocytes. APAP-CM of macrophages from SIRT1-Tg mice failed to downregulate SIRT1 protein levels in hepatocytes. In vivo administration of the NFκB inhibitor BAY 11-7082 preserved SIRT1 levels and protected from APAP-mediated hepatotoxicity.&lt;h4>Innovation&lt;/h4>Our work evidenced the unique role of SIRT1 in APAP hepatoprotection by targeting oxidative stress and inflammation.&lt;h4>Conclusion&lt;/h4>SIRT1 protein levels are downregulated by IL1β/NFκB signaling in APAP hepatotoxicity, resulting in inflammation and oxidative stress. Thus, maintenance of SIRT1 during APAP overdose by inhibiting NFκB might be clinically relevant. Rebound Track: This work was rejected during standard peer review and rescued by Rebound Peer Review (Antioxid Redox Signal 16:293-296, 2012) with the following serving as open reviewers: Rafael de Cabo, Joaquim Ros, Kalervo Hiltunen, and Neil Kaplowitz. Antioxid. Redox Signal. 28, 1187-1208.</pubmed_abstract><journal>Antioxidants &amp; redox signaling</journal><pubmed_title>SIRT1 Controls Acetaminophen Hepatotoxicity by Modulating Inflammation and Oxidative Stress.</pubmed_title><pmcid>PMC9545809</pmcid><funding_grant_id>R42 DK079387</funding_grant_id><pubmed_authors>Simpson KJ</pubmed_authors><pubmed_authors>Garcia-Martinez I</pubmed_authors><pubmed_authors>Sanchez-Ramos C</pubmed_authors><pubmed_authors>Pardo V</pubmed_authors><pubmed_authors>Monsalve M</pubmed_authors><pubmed_authors>Rada P</pubmed_authors><pubmed_authors>Ruiz L</pubmed_authors><pubmed_authors>Alemany S</pubmed_authors><pubmed_authors>James LP</pubmed_authors><pubmed_authors>Valverde AM</pubmed_authors><pubmed_authors>Valdecantos MP</pubmed_authors><pubmed_authors>Gonzalez-Rodriguez A</pubmed_authors><pubmed_authors>Muntane J</pubmed_authors><pubmed_authors>Mobasher MA</pubmed_authors></additional><is_claimable>false</is_claimable><name>SIRT1 Controls Acetaminophen Hepatotoxicity by Modulating Inflammation and Oxidative Stress.</name><description>&lt;h4>Aims&lt;/h4>Sirtuin 1 (SIRT1) is a key player in liver physiology and a therapeutic target against hepatic inflammation. We evaluated the role of SIRT1 in the proinflammatory context and oxidative stress during acetaminophen (APAP)-mediated hepatotoxicity.&lt;h4>Results&lt;/h4>SIRT1 protein levels decreased in human and mouse livers following APAP overdose. SIRT1-Tg mice maintained higher levels of SIRT1 on APAP injection than wild-type mice and were protected against hepatotoxicity by modulation of antioxidant systems and restrained inflammatory responses, with decreased oxidative stress, proinflammatory cytokine messenger RNA levels, nuclear factor kappa B (NFκB) signaling, and cell death. Mouse hepatocytes stimulated with conditioned medium of APAP-treated macrophages (APAP-CM) showed decreased SIRT1 levels; an effect mimicked by interleukin (IL)1β, an activator of NFκB. This negative modulation was abolished by neutralizing IL1β in APAP-CM or silencing p65-NFκB in hepatocytes. APAP-CM of macrophages from SIRT1-Tg mice failed to downregulate SIRT1 protein levels in hepatocytes. In vivo administration of the NFκB inhibitor BAY 11-7082 preserved SIRT1 levels and protected from APAP-mediated hepatotoxicity.&lt;h4>Innovation&lt;/h4>Our work evidenced the unique role of SIRT1 in APAP hepatoprotection by targeting oxidative stress and inflammation.&lt;h4>Conclusion&lt;/h4>SIRT1 protein levels are downregulated by IL1β/NFκB signaling in APAP hepatotoxicity, resulting in inflammation and oxidative stress. Thus, maintenance of SIRT1 during APAP overdose by inhibiting NFκB might be clinically relevant. Rebound Track: This work was rejected during standard peer review and rescued by Rebound Peer Review (Antioxid Redox Signal 16:293-296, 2012) with the following serving as open reviewers: Rafael de Cabo, Joaquim Ros, Kalervo Hiltunen, and Neil Kaplowitz. Antioxid. Redox Signal. 28, 1187-1208.</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 May</publication><modification>2025-04-05T11:37:47.992Z</modification><creation>2025-04-05T11:37:47.992Z</creation></dates><accession>S-EPMC9545809</accession><cross_references><pubmed>29084443</pubmed><doi>10.1089/ars.2017.7373</doi></cross_references></HashMap>